Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Meeting Actions topic
No spam. Unsubscribe anytime.
OPTN executive committee advances three development projects, approves votes by acclimation
Summary
The OPTN Executive Committee voted to advance three project-development efforts—multivisceral transplant pathways, ABO genotyping/subtyping, and liver allocation clarification—and received an HRSA update on OPTN modernization and continuity of operations.
The OPTN Executive Committee approved three project-development motions and heard an update from the Health Resources and Services Administration on the OPTN modernization transition.
At the start of the executive committee call, the chair moved to approve the Dec. 5 executive committee summary; the motion passed using an in-chat voting link (9 approve, 0 reject, 0 abstain). The committee then considered three project-development proposals advanced by the Policy Oversight Committee: increasing priority paths for multivisceral transplant candidates, clarifying molecular ABO genotyping and subtyping, and optimizing components of liver allocation for end-stage liver disease and small-stature patients.
A motion to advance the liver and intestine committee’s multivisceral-transplant project-development proposal was moved and seconded and passed (9 approve, 0 reject, 0 abstain). A second motion to allow the Histocompatibility/ISA committees to develop an ABO genotyping/subtyping project—making molecular ABO genotyping the standard where transfusion history may confound traditional typing—was approved (10 approve, 0 reject, 0 abstain). The committee also approved advancing a liver-committee project to clarify allocation components for cirrhosis, small-stature patients and related end-stage liver disease issues (9 approve, 0 reject, 0 abstain).
Committee officers and members emphasized that these votes authorize project development only; they are not votes on policy. Multiple speakers noted the proposals were previously reviewed in December and described the expected financial impact as modest at this stage.
The meeting adjourned by acclamation after the scheduled business concluded.
